Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for CancerNidal Muvarak, Feyruz V. Rassool, Khadiza Chowdhury et al.|Cancer Cell|2016Cited by 211
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, John C. Byrd, Maria R. Baer et al.|Nature Medicine|2020Cited by 195
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Maria R. Baer, Vu H. Duong et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 56
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Søren M. Bentzen, Jennie Y. Law et al.|Cancer Chemotherapy and Pharmacology|2017Cited by 53
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W. Pratz, Mark J. Levis, Michelle A. Rudek et al.|Transplantation and Cellular Therapy|2019Cited by 43